January 31, 2024

Cryo-TEM Analysis of LNPs Across Mixing Systems, including Bleb Structure Formation

Request a quote

Learn how process changes can affect LNP structure, and how cryo-TEM can reveal the differences.

Experts from Phosphorex, Ian Villamagna, & NanoImaging Services, Dr. Mandy Janssen, will walk you through their research to reveal how process changes, including mixing systems, impact lipid nanoparticle (LNP) structure and morphology, especially bleb formation, and explain the unique properties of cryo-TEM imaging for visualizing individual particles.

High-Resolution Cryo-Electron Microscopy Structure Determination of Haemophilus influenzae Tellurite-Resistance Protein A via 200 kV Transmission Electron Microscopy

Seeing Through the Fog: Using Cryo-TEM to Characterize LNPs During Formulation and Process Changes

Seeing Through the Fog: Cryo-TEM as a Powerful Analytical Tool for LNP Characterization During Development & Manufacturing

Structural basis for the oligomerization-facilitated NLRP3 activation

Cryo-TEM Analysis of LNPs Across Mixing Systems, including Bleb Structure Formation

SPT Labtech and NIS at Microscopy & Microanalysis 2022

Morphological Characterization of Self-Amplifying mRNA Lipid Nanoparticles

Structural and mechanistic insights into the inhibition of respiratory syncytial virus polymerase by a non-nucleoside inhibitor

Cryo-EM for Epitope Mapping

The Glycerol Dilemma: the Tradeoff between Stability and Contrast in Cryo-EM

Purification of a recombinant oncolytic virus from clarified cell culture media by anion exchange monolith chromatography

Stressed stability and protective efficacy of lead lyophilized formulations of ID93+GLA-SE tuberculosis vaccine

Nonclinical pharmacokinetics and biodistribution of VSV-GP using methods to decouple input drug disposition and viral replication

Immunogenicity and protection of a variant nanoparticle vaccine that confers broad neutralization against SARS-CoV-2 variants

Absolute Configuration Determination of Chiral API Molecules by MicroED Analysis of Cocrystal Powders Formed Based on Cocrystal Propensity Prediction Calculations

The Resolution Revolution

Integrative structural and functional analysis of human malic enzyme 3: A potential therapeutic target for pancreatic cancer

Quality Control of AAV Production with Cryo-TEM

How VLP Structural Insights from Cryo-TEM Helped Characterize the GARDASIL® Vaccine

Absolute configuration determination of SMTP-7 via microcrystal electron diffraction (MicroED)

Harness the Power of Cryo-EM

Nanoparticle Characterization Tips

Anellovirus Structure Reveals a Mechanism for Immune Evasion

IMM-BCP-01, a patient-derived anti-SARS-CoV-2 antibody cocktail, is active across variants of concern including Omicron BA.1 and BA.2

CELLOPT: improved unit-cell parameters for electron diffraction data of small-molecule crystals

From Powders to Single Crystals: A Crystallographer's Toolbox for Small-Molecule Structure Determination

An anti-ANGPTL3/8 antibody decreases circulating triglycerides by binding to a LPL-inhibitory leucine zipper-like motif

Absolute configuration determination of pharmaceutical crystalline powders by MicroED via chiral salt formation

Structural arrangement of the VH and VL domains in the COBRA T-cell engaging single-chain diabody

Routine collection of 10,000 direct detector movies a day using Leginon

Cryo-EM structures of inhibitory antibodies complexed with arginase 1 provide insight into mechanism of action

Small Molecule Microcrystal Electron Diffraction for the Pharmaceutical Industry Lessons Learned From Examining Over Fifty Samples

Optimizing a Multi-Component Intranasal Entamoeba Histolytica Vaccine Formulation Using a Design of Experiments Strategy

Real-Time Cryo-Electron Microscopy Analysis with cryoSPARC

Sugar phosphate activation of the stress sensor eIF2B

SARS-CoV-2 spike glycoprotein vaccine candidate NVX-CoV2373 immunogenicity in baboons and protection in mice

Cryo-EM: Perspectives of an Industrial Crystallographer

Electron Microscopy in Virus Structural Biology and Vaccine Development

NIS Mountain Hero